Cargando…
Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors
BACKGROUND: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9is) are an important but underutilised option to help optimise lipid management. We developed a new service to improve patient access to these medicines in line with National Institute for Health and Care Excellence recommend...
Autores principales: | Khatib, Rani, Khan, Mutiba, Barrowcliff, Abigail, Ikongo, Eunice, Burton, Claire, Mansfield, Michael, Hall, Alistair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991064/ https://www.ncbi.nlm.nih.gov/pubmed/35393352 http://dx.doi.org/10.1136/openhrt-2021-001931 |
Ejemplares similares
-
Harnessing digital health to optimise the delivery of guideline-based cardiac rehabilitation during COVID-19: an observational study
por: Gibson, Irene, et al.
Publicado: (2023) -
Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction
por: Hurdus, Ben, et al.
Publicado: (2020) -
Age at period cessation and trajectories of cardiovascular risk factors across mid and later life
por: O'Keeffe, Linda Marie, et al.
Publicado: (2020) -
Sex differences in the association between childhood maltreatment and cardiovascular disease in the UK Biobank
por: Soares, Ana Luiza Gonçalves, et al.
Publicado: (2020) -
Improving detection and management of familial hypercholesterolaemia in Australian general practice
por: Brett, Tom, et al.
Publicado: (2021)